HIGH

ETHICON Recalls Tissue Control Device for Barb Non-Engagement Risk

ETHICON recalled 516 units of the STRATAFIX Spiral PDS Plus device on August 15, 2025. The recall follows reports of potential barb non-engagement that could affect surgical procedures. Healthcare providers and patients must stop using the device immediately.

Quick Facts at a Glance

Recall Date
August 15, 2025
Hazard Level
HIGH
Brand
ETHICON
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Potential for barb non-engagement.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact ETHICON, LLC or your healthcare provider for instructions. Notification method: Letter

Product Details

The recalled product is the STRATAFIX Spiral PDS Plus Bidirectional Knotless Tissue Control Device, Product Code SXPP2B400-11. It was distributed in the U.S. states of AR, AZ, CA, IL, IN, KS, MA, MD, MI, MO, MN, NC, NH, NM, TX, VA, WA, WI, and in Singapore and Malaysia.

The Hazard

The recall warns of potential barb non-engagement, which can compromise surgical procedures. This defect poses a high hazard level and could lead to complications during surgery.

Reported Incidents

No specific incidents related to injuries or complications have been reported so far. The hazard level is classified as high due to the potential risk during surgical applications.

What to Do

Patients and healthcare providers should stop using the device immediately. Follow the recall instructions provided by ETHICON, LLC or contact your healthcare provider for further instructions.

Contact Information

For more information, contact ETHICON, LLC. Visit the FDA recall page for additional details: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2605-2025.

Key Facts

  • 516 units recalled
  • High hazard level due to barb non-engagement
  • Distributed worldwide
  • Follow recall instructions immediately

Get Alerts for Health & Personal Care Recalls

Get notified about recalls in categories you care about.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Brand
Model Numbers
Product Code: SXPP2B400-11.
GTIN: 10705031464568
30705031464562
Affected States
ALL
Report Date
October 1, 2025
Source Agency
FDA - Medical Devices
Recall Status
ACTIVE

Related Recalls

HIGH

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]

CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

SUCRALFATE
CGMP Deviations:
Read more